FOS and neoplasm: The increasing literature on the tumor suppressive role of c‐Jun 39, its association with HDAC 40, and the higher nuclear expression pattern of c‐Jun compared to other AP‐1 members in human NE tumors41 prompted us to select c‐Jun for further binding studies.